Bio-Thera Begins Phase 1 Trial of BAT4306F in Advanced B-cell Non-Hodgkin’s Lymphoma
News
Bio-Thera Solutions has started dosing patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma with its investigational therapy BAT4306F in a Phase 1 clinical trial. Taking place in China, the trial (ChiCTR1800018900) ... Read more